U.K. Authorizes COVID-19 Vaccine

The U.K. became the first Western nation to grant emergency-use authorization for a Covid-19 vaccine, clearing a shot developed by Pfizer Inc. of the U.S. and BioNTech SE of Germany to be distributed in limited […]

By |2020-12-03T11:02:24-05:00December 3, 2020|Articles|Comments Off on U.K. Authorizes COVID-19 Vaccine
Read More

Pfizer Shows Positive Vaccine Data

The drug maker Pfizer announced on Monday that an early analysis of its coronavirus vaccine trial suggested the vaccine was robustly effective in preventing Covid-19, a promising development as the world has waited anxiously for […]

By |2020-11-10T12:14:31-05:00November 10, 2020|Articles|Comments Off on Pfizer Shows Positive Vaccine Data
Read More

Risk Disclaimer

Content is for Informational Purposes

The results described in testimonials or otherwise on the Website or elsewhere by PROVIDER are not indicative of the results individual investors may generally expect to achieve. Users should not expect to experience similar results.

NEITHER PROVIDER NOR ANY THIRD PARTY HAS VERIFIED THE TRUTH OR ACCURACY OF THE RESULTS OR EXPERIENCES DESCRIBED IN THESE TESTIMONIALS.

Trading securities and other financial instruments can involve high risk and the loss of all amounts invested. Trading securities and other financial instruments on margin or with other forms of leverage or borrowings can result in losses in excess of the amount invested. Investment related information provided may not be appropriate for many investors, and is provided without respect to individual investor financial sophistication, financial situation, investing time horizon, or risk tolerance. Such information is for general information purposes only. None of such information is meant to constitute investment or financial advice.

[Read Full Terms & Disclaimers]

Bubba Trading
Post Office Box 7202
Deerfield, Illinois 60015
United States of America
Contact

Thank you for visiting Bubba Trading. We use cookies to improve your experience during your sojourn, prior & future purchases, and all other interactions herein. Your continued use of the site constitutes your freely-given explicit consent to our company user policies and that you being of sound-mind understand the implications thereof. To find out more, read our privacy policy , general visitor terms of use, and/or the subscriber & customer terms of use. If you wish not to consent to said policies, you must leave the site immediately and are forbidden to return until such time as you opt to freely & explicitly consent to our aforementioned & hyperlinked policies.

 Ok